Evidence map›Paper›PMID 32986250›Full record

ArticleJournal of medical virology2021

A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: An ecological approach.

José Pablo Romero-López, Martha Carnalla-Cortés, Diana L Pacheco-Olvera, Juan Moisés Ocampo-Godínez, Jacqueline Oliva-Ramírez, Julia Moreno-Manjón, Brian Bernal-Alferes, Nancy López-Olmedo, Ethel García-Latorre, María Lilia Domínguez-López and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
0.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The role of HLA genotypes in understanding the pathogenesis of severe COVID-19.The Egyptian journal of medical human genetics · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Host polymorphisms and COVID-19 infection.Advances in clinical chemistry · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

José Pablo Romero-LópezCarrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, UNAM, Avenida de los Barrios 1, Tlalnepantla de Baz, Estado de México, Mexico.ORCID 0000-0002-0140-7676
Martha Carnalla-CortésCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico.ORCID 0000-0003-1427-2915
Diana L Pacheco-OlveraLaboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.
Juan Moisés Ocampo-GodínezCarrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, UNAM, Avenida de los Barrios 1, Tlalnepantla de Baz, Estado de México, Mexico.ORCID 0000-0001-5666-4672
Jacqueline Oliva-RamírezEscuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Mexico City, Mexico.ORCID 0000-0001-9334-2066
Julia Moreno-ManjónLaboratorio de Infectología, Microbiología e Inmunología Clínicas, Unidad de Investigación en Medicina Experimental, Facultad de Medicina, UNAM, Mexico City, Mexico.
Brian Bernal-AlferesLaboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.
Nancy López-OlmedoCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico.ORCID 0000-0002-7528-0954
Ethel García-LatorreLaboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.ORCID 0000-0002-0223-4033
María Lilia Domínguez-LópezLaboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.ORCID 0000-0002-2533-1215
Arturo Reyes-SandovalNuffield Department of Medicine, The Jenner Institute, The Henry Welcome Building for Molecular Physiology, University of Oxford, Oxford, UK.ORCID 0000-0002-2648-1696
Luis Jiménez-ZamudioLaboratorio de Inmunología Clínica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.ORCID 0000-0001-8007-9027
Instituto Politécnico Nacional · MXAutonomous University of Tlaxcala · MXInstituto Nacional de Salud Pública · MXCentro Medico Nacional Siglo XXI · MXTecnológico de Monterrey · MXUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 infection is causing a pandemic disease that is reflected in challenging public health problems worldwide. Human leukocyte antigen (HLA)-based epitope prediction and its association with disease outcomes provide an important base for treatment design. A bioinformatic prediction of T cell epitopes and their restricted HLA Class I and II alleles was performed to obtain immunogenic epitopes and HLA alleles from the spike protein of the severe acute respiratory syndrome coronavirus 2 virus. Also, a correlation with the predicted fatality rate of hospitalized patients in 28 states of Mexico was done. Here, we describe a set of 10 highly immunogenic epitopes, together with different HLA alleles that can efficiently present these epitopes to T cells. Most of these epitopes are located within the S1 subunit of the spike protein, suggesting that this area is highly immunogenic. A statistical negative correlation was found between the frequency of HLA-DRB1*01 and the fatality rate in hospitalized patients in Mexico.

Indexed as

Antigen PresentationCOVID-19Computational BiologyEpitopes, T-LymphocyteGenetic VariationHLA-DRB1 ChainsHospitalizationHumansMexicoProtein Structure, TertiarySARS-CoV-2Spike Glycoprotein, CoronavirusEpitopes, T-LymphocyteHLA-DRB1*01 antigenHLA-DRB1 ChainsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID32986250
PMCPMC7537233
OpenAlexW3088269781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.